W15--New Horizons in CF Newborn Screening: Advancements & Updates

Thursday, October 23, 2025

10:15 AM - 12:15 PM PDT

Location:Ballroom 3

Chair(s)

Marci Sontag, PhD

Center for Public Health Innov
Rachel Linnemann, MD

Department of Pediatrics
Department of Pediatrics, Division of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine

This session will highlight emerging data and advancements in CF newborn screening. Topics will include barriers to timely diagnosis, quality improvement efforts to enhance newborn screening processes, updates in newborn screening lab methodology, variant reporting after sequencing, diagnostic uncertainty, and considerations for new guideline implementation.

Learning Objectives:

Summarize emerging data on CF newborn screening strategies and challenges
Identify quality improvement strategies and newborn screening laboratory methodologies to enhance timely diagnosis
Describe considerations for implementation of the new CF Foundation newborn screening guidelines

Presentations:

10:15 AM - 12:15 PM PDT

W15.1- Reducing the age at first event in infants with a positive cystic fibrosis newborn screen in Arkansas: A quality improvement initiative
Speaker: Ariel Berlinski, MD – University of Arkansas for Medical Sciences
10:15 AM - 12:15 PM PDT

W15.2- CF Newborn Screening Notification Practices and Time to Evaluation
Speaker: Clement Ren, MD – Children's Hospital of Philadelphia
10:15 AM - 12:15 PM PDT

W15.3 - Ohio CF Newborn Screening Collaborative – Moving Ohio forward
Speaker: Katelyn Krivchenia, MD – Nationwide Children's Hospital
10:15 AM - 12:15 PM PDT

W15.4- Longitudinal Evaluation of a High Functioning CF Newborn Screening Program.
Speaker: Melanie Sue Collins, MD – Connecticut Childrens Medical Center
10:15 AM - 12:15 PM PDT

W15.5- Cystic fibrosis newborn screening: Policy and finance considerations for adopting Next-Generation Sequencing and reducing disparities
Speaker: Marci Sontag, PhD – Center for Public Health Innov